XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Licensing revenue $ 125,000 $ 125,000 $ 375,000 $ 375,000
Operating expenses:        
Research and development 2,408,680 2,468,066 8,730,395 7,633,051
General and administrative 3,890,886 2,718,510 9,639,419 8,258,271
Total operating expenses 6,299,566 5,186,576 18,369,814 15,891,322
Loss from operations (6,174,566) (5,061,576) (17,994,814) (15,516,322)
Other (expense) income:        
Loss from change in valuation of earn-out milestone liability (257,000) (327,000)
Investment income 153,301 3,552 205,760 5,614
Interest expense (127,025) (95,520) (4,878,306) (474,361)
Recognized loss on extinguishment of debt (234,419)
Other income (expense) 1,801 (1,456)
Total other income (expense), net 26,276 (348,968) (4,670,745) (1,031,622)
Net loss $ (6,148,290) $ (5,410,544) $ (22,665,559) $ (16,547,944)
Net loss per common share        
Basic and diluted $ (0.87) $ (0.94) $ (3.42) $ (3.12)
Weighted average shares outstanding        
Basic and diluted 7,098,741 5,770,516 6,621,925 5,311,174